| Tag | Content |
|---|
EnhancerAtlas ID | HS073-01171 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr1:182598410-182600430 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEOX1 | MA0661.1 | chr1:182600000-182600010 | GCTAATTAAC | + | 6.02 | | NFIL3 | MA0025.1 | chr1:182598479-182598490 | TTATGTAACCT | + | 6.14 | | REST | MA0138.2 | chr1:182599255-182599276 | ATTAGCACCCTGGCCAGCACA | + | 6.65 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_33596 | chr1:182597819-182600665 | H2171 | | SE_58767 | chr1:182569958-182622446 | Ly1 | | SE_61551 | chr1:182562351-182619258 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I182628 | chr1 | 182597820 | 182600665 |
|
Enhancer Sequence | GAGTGAGATC AGAGGCCTTC TCCTGCAGCT GGCTCCATAG GAAGCAGTAA TAAAAGCATC 60
GCCTTGCTCT TATGTAACCT TTTACTATTT ATAAAACACT TTCATATACC TTATCTCAAA 120
AAAGAGCTCC CAAATATCTT CCCTACTCAC AAAGACACAA AGACAAGCAA ATATCCCAGA 180
GTTTCAAACA TAAGGAGGGT AGGGGAGAGA AGACAGGCCG CATTTTCAAC CAGGACAAAA 240
TTCAGCTCCT CTTGCATGGT GAGCAGGGCA CCCAAAGGGC CTTGTGATTA AACTCTTCCT 300
TCTCTCCCAA ATTCTGACTG ATGCTTAAAA TCTCACCAAC TGTTATCCCC AACTTGGTGT 360
AACTGAGGCT TTTGTCTCAG CTAAATGCAA ATGTGGCTGT TGTGATGGGC ACACATTAGT 420
CACCCTCCAT TTACCACATA GTGTGGCAGG ATTGGCTCTG TGGAAAGGTC AGTAATGAAT 480
GGCAGGGATA TTTCTAACTG AGCTGGGGAC CTCCAGAGCC ACCTTGCCCT CTGAAGTCTC 540
ATAACTGTGC CCTGGTCAAA ATCCGCAGAC ACCACCCCCG CCTCTGAGTT AGACAGGCAG 600
GGGTGACCTA AGATACAGGA TGCCCTTACT TCCTGTCTGT GGCAGCGGGC AACACCCACC 660
ACCATCAGTC ACCTCCACCC CCACTCCTGG TTTCTGCACC CACATTTTCA CTGTTTATCT 720
CTGGATAACC CCATCTGACC TAAGAAACTG TGGCAAGTCT GTTTCTTACC TAGAAAATGA 780
ATATTTGGAG ACATTCAATG GTTAGATACT GTGAAGATTT TTTTTTTAAG TATATAAAAA 840
GCTTAATTAG CACCCTGGCC AGCACATAAT GGGTGTTCAG TATATCTCTG TTTTGAAAAT 900
AAATGGCAGA ATTCACTCCA GGCTTCCTGT CTGTCCCACA GACCGAATCA TGCTGCTGGA 960
CTGGGCTAAG TCACATTTTT GATAAAAAGA GGTAACTTTC TCCAGCCAAG CCTAACAAGC 1020
TTTAAAAGGC CTATGGTTTA TAAAATCACC AGTGCCCCTC ATCAGCCCTC TCCCCCAGTT 1080
TCCCTCACCA TCAGGGCTCT CCAGAATTGC TGTTCAGTGA TCTCTTTTCC CTCCTGGGAC 1140
TGCTCTGATT GTCCTATTTC CTTGGTTCCA TGTGGCACAC GGTTGAGAAA AGAGGCACCT 1200
GTGCGTGTGA CTTGTCACAT CTTTTCCCAG CGTTCTGCTC CCATGGATAT GGGGCTCAGG 1260
AGGCATGGTT GGGAATCAGG AAACTGCTTC CAACCCCATG ACAAATGTCA CCTATCTGTC 1320
CTACCAATTT GTCAGCATTG AAACTCAAAG TGACACTTTC CTGCCAAATC TAGATAAAGC 1380
CATTTCCACT CCAGTCGGAG TGAGTGTACC AGCCAATCTC CCAGAGGGAA ACTAGGGTTC 1440
TGGAGAGGAT ATGGGGTTCA GATTCAGCAA ATGTTTTTGG AATGTCCACT CTGTGCCCAG 1500
CATTGTGTTG GTTGTGAGTA TGTGTGCTTA GTTTACATTC CAAGCATTCC AAGTTGCATT 1560
ACACAGATGA GAAAAGCAGG GCTCAGTAAG GCTAATTAAC TTGCCCACCT ACAGCCAGTG 1620
AGTGAGAATC TCAAGATTTT ACAAGATTTT ATAGCTCCAA GTTCCAATCC AAGATACTTT 1680
CCATTAAGCC CATGGATGTC ATTTCAGGTG CAACCTCAGA CCACCTTCTC CAGTATCCTC 1740
CTAGAATATT ACAGATCACA CAGTCTCTCT CCCCTCTGAA CACCAAGAGC ATGGCCATGT 1800
GTCCTTTCCA CCTGTGAGTG AGCCTCACAA AGGACTGGAA GCTACCTAGG CTCAAGAGTT 1860
GTGCCTTCTT TCATCCACTG ATGGAATGCA GGGCACACAG GAAAACAAGA GTGTACTGGG 1920
GGCACTGAAT AGTCTCAAAG CCTTCTCATA TATCCTGTTC CCACAACTCT GTAACATAGG 1980
ACAGGGAAGA TTTATTTGCT CTGGGGTGGA GCAGGAGGGT 2020
|
